|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0008976,
umls-concept:C0010068,
umls-concept:C0023820,
umls-concept:C0030705,
umls-concept:C0233820,
umls-concept:C0441471,
umls-concept:C0547047,
umls-concept:C0580822,
umls-concept:C1512612,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C1705117,
umls-concept:C2349179,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-1-22
|
|
pubmed:abstractText |
Few studies have looked into the ability of measurements of apolipoprotein B (apoB) and apolipoprotein A-1 (apoA-1) or apoB/apoA-1 to predict new coronary heart disease (CHD) events in patients with CHD on statin treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0785-3890
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
456-64
|
|
pubmed:dateRevised |
2009-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:19160529-Aged,
pubmed-meshheading:19160529-Anticholesteremic Agents,
pubmed-meshheading:19160529-Apolipoprotein A-I,
pubmed-meshheading:19160529-Apolipoproteins B,
pubmed-meshheading:19160529-Biological Markers,
pubmed-meshheading:19160529-Cholesterol, HDL,
pubmed-meshheading:19160529-Cholesterol, LDL,
pubmed-meshheading:19160529-Female,
pubmed-meshheading:19160529-Heptanoic Acids,
pubmed-meshheading:19160529-Humans,
pubmed-meshheading:19160529-Hypercholesterolemia,
pubmed-meshheading:19160529-Male,
pubmed-meshheading:19160529-Middle Aged,
pubmed-meshheading:19160529-Myocardial Infarction,
pubmed-meshheading:19160529-Odds Ratio,
pubmed-meshheading:19160529-Predictive Value of Tests,
pubmed-meshheading:19160529-Pyrroles,
pubmed-meshheading:19160529-Simvastatin,
pubmed-meshheading:19160529-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL).
|
|
pubmed:affiliation |
Center of Preventive Medicine, Ullevål University Hospital, Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
